thiazoles has been researched along with noscapine in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
SAKURAI, H; UMEDA, M | 1 |
Bansal, S; Chandra, R; Kasi Sankar, V; Singh, J; Tandon, V; Tiwari, RK; Verma, AK | 1 |
Pagadala, NS; Perez-Pineiro, R; Tuszynski, JA; Wishart, DS | 1 |
Chowdhury, N; Doddapaneni, R; Patel, K; Singh, M | 1 |
4 other study(ies) available for thiazoles and noscapine
Article | Year |
---|---|
[COLOR OF PHENOLS. IV. COLORIMETRIC DETERMINATION OF THEBAINE WITH 3-METHYL-2-BENZOTHIAZOLINONE HYDRAZONE-CERIUM AMMONIUM SULFATE METHOD].
Topics: Ammonium Compounds; Ammonium Sulfate; Benzothiazoles; Cerium; Chemistry, Pharmaceutical; Codeine; Color; Colorimetry; Hydrazones; Morphine; Noscapine; Papaverine; Phenols; Quaternary Ammonium Compounds; Research; Sulfates; Thebaine; Thiazoles | 1963 |
Synthesis and in vitro cytotoxicity of haloderivatives of noscapine.
Topics: Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Glioblastoma; Humans; Indicators and Reagents; Kinetics; Noscapine; Tetrazolium Salts; Thiazoles | 2006 |
In silico studies and fluorescence binding assays of potential anti-prion compounds reveal an important binding site for prion inhibition from PrP(C) to PrP(Sc).
Topics: Animals; Binding Sites; Drug Design; Humans; Kinetics; Ligands; Molecular Docking Simulation; Molecular Dynamics Simulation; Neuroprotective Agents; Noscapine; Protein Binding; Protein Structure, Secondary; Protein Structure, Tertiary; PrPC Proteins; PrPSc Proteins; Quantitative Structure-Activity Relationship; Quinolines; Spectrometry, Fluorescence; Static Electricity; Structural Homology, Protein; Thermodynamics; Thiazoles | 2015 |
Noscapine chemosensitization enhances docetaxel anticancer activity and nanocarrier uptake in triple negative breast cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Migration Assays; Cell Movement; Coumarins; Docetaxel; Drug Carriers; Enzyme Activation; Fluorescent Antibody Technique; Humans; JNK Mitogen-Activated Protein Kinases; Liposomes; Mice; Microtubules; Nanoparticles; Noscapine; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Polymerization; Staining and Labeling; Taxoids; Thiazoles; Triple Negative Breast Neoplasms; Tubulin; Xenograft Model Antitumor Assays | 2016 |